Literature DB >> 16221723

Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.

Hideki Kasahara1, Eiji Matsuura, Keiko Kaihara, Daisuke Yamamoto, Kazuko Kobayashi, Junko Inagaki, Kenji Ichikawa, Akito Tsutsumi, Shinsuke Yasuda, Tatsuya Atsumi, Tatsuji Yasuda, Takao Koike.   

Abstract

Beta2-glycoprotein I (beta2-GPI) is a major antigen for anti-cardiolipin antibodies and their epitopes are cryptic. Conformation of each domain of beta2-GPI was optimized from its crystal structure by energy minimization and by molecular dynamics simulation. Three electrostatic interactions, i.e. D193-K246, D222-K317 and E228-K308, were observed between domains IV and V in the optimized structure that was constructed based on the consensus sequences obtained by the phage-displayed random peptide library. Antigenic structures determined by the epitope mapping mainly consisted of hydrophobic amino acids located on two discontinuous sequences in domain IV. These amino acid clusters, as an epitope, were covered by domain V and were of a hidden nature. A similar but incomplete counterpart to the epitopic clusters was found in domain I but was not in domains II or III. Binding of anti-beta2-GPI auto-antibodies to solid-phase beta2-GPI was significantly reduced either by L replacement for W235, a common amino acid component for the epitopes, or by V replacement for all of D193, D222 and E228. Structural analysis indicated a hypothesis that these electrostatic interactions between domains IV and V retained exposure to W235 and that epitope spreading occurred in the region surrounding W235. Thus, epitopic structures recognized by anti-beta2-GPI auto-antibodies are cryptic and inter-domain electrostatic interactions are involved in their in exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221723     DOI: 10.1093/intimm/dxh330

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Authors:  A Artenjak; I Locatelli; H Brelih; D M Simonič; Z Ulcova-Gallova; J Swadzba; J Musial; T Iwaniec; L Stojanovich; F Conti; G Valesini; T Avčin; J W Cohen Tervaert; Y Shoenfeld; M Blank; A Ambrožič; S Sodin-Semrl; B Božič; S Čučnik
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Authors:  Vadim Pedchenko; Olga Bondar; Agnes B Fogo; Roberto Vanacore; Paul Voziyan; A Richard Kitching; Jörgen Wieslander; Clifford Kashtan; Dorin-Bogdan Borza; Eric G Neilson; Curtis B Wilson; Billy G Hudson
Journal:  N Engl J Med       Date:  2010-07-22       Impact factor: 91.245

3.  β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.

Authors:  Kenji Tanimura; Hui Jin; Tadahiro Suenaga; Satoko Morikami; Noriko Arase; Kazuki Kishida; Kouyuki Hirayasu; Masako Kohyama; Yasuhiko Ebina; Shinsuke Yasuda; Tetsuya Horita; Kiyoshi Takasugi; Koichiro Ohmura; Ken Yamamoto; Ichiro Katayama; Takehiko Sasazuki; Lewis L Lanier; Tatsuya Atsumi; Hideto Yamada; Hisashi Arase
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

4.  Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.

Authors:  Jingda Li; Yan Chi; Shuqian Liu; Le Wang; Renjun Wang; Xiaofei Han; Eiji Matsuura; Qingping Liu
Journal:  J Clin Immunol       Date:  2014-06-27       Impact factor: 8.317

5.  Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin.

Authors:  Miyuki Bohgaki; Masaki Matsumoto; Tatsuya Atsumi; Takeshi Kondo; Shinsuke Yasuda; Tetsuya Horita; Keiichi I Nakayama; Fumihiko Okumura; Shigetsugu Hatakeyama; Takao Koike
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

6.  Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.

Authors:  Ilan Volkov; Luciana Seguro; Elaine P Leon; László Kovács; Dirk Roggenbuck; Peter Schierack; Boris Gilburd; Andrea Doria; Maria G Tektonidou; Nancy Agmon-Levin
Journal:  Auto Immun Highlights       Date:  2020-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.